Clinical Trial Update: Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating nicotinamide treatment for lupus-associated skin lesions in lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus
• Systemic Lupus Erythematosus Rash

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus Rash | Phase 2 | Status: UNKNOWN